The unlimited potential of AI & RNA
We started ShapeTX with the vision of repairing the genetic causes of disease.
We’re realizing that vision by combining AI and RNA technology to make programmable RNA medicine available for everyone.
Board of Directors
Ed Mathers
General Partner, New Enterprise Associates
Min Cui, PhD
Founder & Managing Partner, Decheng Capital
Josef von Rickenbach, PhD
Founder & Former CEO, Parexel
David Epstein
Former CEO, Seagen; Former CEO, Novartis Pharmaceuticals
Todd Simpson
Former CFO, Seagen
Leadership
Prashant Mali, PhD
Co-Founder
Professor, Department of Bioengineering, University of California San Diego
David Huss, PhD
Interim CEO and Chief Scientific Officer
Lisa Taylor Ash, JD
General Counsel and
Head of Operations
Patrick Bigot, MBA
Chief Business Officer
Adrian Briggs, PhD
Chief Technology Officer
Ron Hause, PhD
SVP, Head of AI
Ken Prentice
SVP, Process & Product Development
Matt Valentino
Chief People Officer
Scientific Advisory Board
George Church, PhD
Professor, Genetics, Harvard Medical School
Don Cleveland, PhD
Professor, Cellular Molecular Medicine, UCSD
James Collins, PhD
Professor, Bioengineering, MIT
You. And a universe of possibilities.
If you are ready to think completely differently about science, join us.